These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21606605)

  • 21. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
    Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M
    Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development.
    Offman E; Edginton AN
    Xenobiotica; 2013 Jun; 43(6):561-9. PubMed ID: 23244626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic investigation of the preclinical pharmacokinetics and interspecies scaling of PF-05231023, a fibroblast growth factor 21-antibody protein conjugate.
    Giragossian C; Vage C; Li J; Pelletier K; Piché-Nicholas N; Rajadhyaksha M; Liras J; Logan A; Calle RA; Weng Y
    Drug Metab Dispos; 2015 Jun; 43(6):803-11. PubMed ID: 25805881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins.
    Yokoyama M; Suzuki E; Oitate M; Watanabe N
    Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):541-552. PubMed ID: 37530974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple Approach to Accurately Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies after Subcutaneous Injection in Humans.
    Haraya K; Tachibana T
    Clin Pharmacokinet; 2021 Jan; 60(1):111-120. PubMed ID: 32779124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of humanized monoclonal anti-IL-13 antibodies with different IL-13 neutralization mechanisms.
    Vugmeyster Y; Szklut P; Tchistiakova L; Abraham W; Kasaian M; Xu X
    Int Immunopharmacol; 2008 Mar; 8(3):477-83. PubMed ID: 18279802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic allometric scaling of antibodies: application to the first-in-human dose estimation.
    Mahmood I
    J Pharm Sci; 2009 Oct; 98(10):3850-61. PubMed ID: 19177515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Human Pharmacokinetics Profile of Monoclonal Antibody Using hFcRn Transgenic Mouse Model.
    Nakamura G; Ozeki K; Takesue H; Tabo M; Hosoya KI
    Biol Pharm Bull; 2021; 44(3):389-395. PubMed ID: 33642546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods.
    Liu D; Ma X; Liu Y; Zhou H; Shi C; Wu F; Jiang J; Hu P
    Eur J Pharm Sci; 2016 Jun; 89():73-82. PubMed ID: 27108678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interspecies allometric scaling. Part I: prediction of clearance in large animals.
    Mahmood I; Martinez M; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR.
    Morris ME; Yang X; Gandhi YA; Bhansali SG; Benincosa LJ
    Biopharm Drug Dispos; 2012 Jan; 33(1):1-14. PubMed ID: 22170504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A translational platform PBPK model for antibody disposition in the brain.
    Chang HY; Wu S; Meno-Tetang G; Shah DK
    J Pharmacokinet Pharmacodyn; 2019 Aug; 46(4):319-338. PubMed ID: 31115858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of allometric scaling exponents for IgG mAbs.
    Rowland SP; Nixon E; Mohan K; Wang Q; Yates JWT
    Xenobiotica; 2024 Sep; 54(9):609-614. PubMed ID: 39067010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma.
    Kamath AV; Lu D; Gupta P; Jin D; Xin Y; Brady A; Stephan JP; Li H; Tien J; Qing J; Damico-Beyer LA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1071-8. PubMed ID: 22203368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human Clearance.
    Mahmood I
    Antibodies (Basel); 2021 Jan; 10(1):. PubMed ID: 33430196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interspecies allometric meta-analysis of the comparative pharmacokinetics of 85 drugs across veterinary and laboratory animal species.
    Huang Q; Gehring R; Tell LA; Li M; Riviere JE
    J Vet Pharmacol Ther; 2015 Jun; 38(3):214-26. PubMed ID: 25333341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting oral clearance in humans: how close can we get with allometry?
    Sinha VK; De Buck SS; Fenu LA; Smit JW; Nijsen M; Gilissen RA; Van Peer A; Lavrijsen K; Mackie CE
    Clin Pharmacokinet; 2008; 47(1):35-45. PubMed ID: 18076217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2.
    Lee WS; Shim SR; Lee SY; Yoo JS; Cho SK
    Drug Des Devel Ther; 2018; 12():495-504. PubMed ID: 29563774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.